.Zevra Therapeutics' uncommon disease drug seems to be on the path to confirmation this loss after g...
.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failure has gone a $230 million...
.After more than twenty years of deal with neurodegenerative conditions, Swiss biotech a/c Immune sy...
.GSK has broken up a period 2 human papillomavirus (HPV) vaccination coming from its pipeline after ...
.OS Therapies are going to note on the NYSE American inventory substitution this morning by means of...
.ALX Oncology's phase 2 gastric cancer cells feedback price has diminished. After finding its CD47 b...
.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of as...
.While Biogen's pharma peers are actually seeking for late-stage possessions with little risk, CEO C...
.Instil Bio has actually been actually a biotech looking for a pipe after it ditched its lead resour...
.Biogen has actually handed back liberties to an early Alzheimer's illness system to Denali Therapeu...